AUPH vs DTE
Aurinia Pharmaceuticals Inc (AUPH) versus DTE (DTE) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
DTE (DTE) common stock.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
DTE does not have a complete income-statement cache yet.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. DTE currently screens at market cap $0.
Not investment advice. Open the AUPH and DTE stock pages for the full models.
Not investment advice.